Document ID: chunk:federal_register_of_legislation:F2025L00212:clause:1_2644
Version: federal_register_of_legislation:F2025L00212
Segment Type: clause
Provision Reference: sch 1 cl 2644
Character Range: 1222010–1223276

2644                                      HYDROXYCITRIC ACID                                         A         The requirements specified below apply to a medicine that contains the ingredient that is:
                                                                                                               - listed in the Register on or after 1 March 2025; or
                                                                                                               - released for supply on or after 1 March 2026.
                                                                                                               When for oral use, the following warning statement is required on the medicine label:
                                                                                                               'In very rare cases, hydroxycitric acid may harm the liver. Stop use and see a doctor if you have yellowing skin/eyes or unusual: fatigue, nausea, appetite loss, abdominal pain, dark urine, or itching.'
                                                                                                               Medicines containing hydroxycitric acid must not be directed for use in children, or in pregnant or lactating women.